Skip to main navigation Skip to search Skip to main content

Eledon Pharmaceuticals To Present Updated Data From Ongoing Phase 1B Trial Of Tegoprubart In Patients Undergoing Kidney Transplantation At The American Transplant Congress

  • Allan Kirk

Press/Media

Period9 May 2024

Media coverage

94

Media coverage